Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z F Xu

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 27, 2025
[Prognostic value of the FS-15 frailty score in patients with myelodysplastic syndromes]X Wang, T J Qin, Z F Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 23, 2018
[Targeted sequencing analysis of hyper-eosinophilic syndrome and chronic eosinophilic leukemia]S Q Qu, T J Qin, Z F Xu, et al.
Oncogene|October 18, 2011
Cross-talk between endothelial cells and tumor via delta-like ligand 4/Notch/PTEN signaling inhibits lung cancer growthX-Y Ding, J Ding, K Wu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 2, 2016
[Analysis of prognostic factors in Chinese patients with post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis]M Chen, Z F Xu, J Q Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 22, 2017
[The clinical characteristics, gene mutations and prognosis of chronic neutrophilic leukemia]Y J Cui, Q Jiang, J Q Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 4, 2024
[Clinical characteristics and prognosis of patients with myelodysplastic syndrome with a bone marrow nucleated erythroid cell proportion of greater than or equal to 50]Y P Zeng, B Li, T J Qin, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 17, 2025
[Myelodysplastic neoplasms with acute myeloid leukemia-like mutations: clinical features, molecular profiles, and prognosis]Z F Bao, L L Liu, B Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 15, 2021
[Genetic characteristics and prognostic values of RAS mutations in patients with myelofibrosis]J Y Wu, B Li, Y J Jia, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 1, 2019
[Clinical implications and prognostic value of TP53 gene mutation and deletion in patients with myelodysplastic syndromes]H J Huang, Z X Shi, B Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 3, 2016
[Frequency and clinical features of ASXL2 gene mutation in acute myeloid leukemia patients with AML1- ETO fusion gene positive]J X Zhao, X H Chen, J L Li, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 27, 2025
[Prognostic value of the FS-15 frailty score in patients with myelodysplastic syndromes]X Wang, T J Qin, Z F Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 23, 2018
[Targeted sequencing analysis of hyper-eosinophilic syndrome and chronic eosinophilic leukemia]S Q Qu, T J Qin, Z F Xu, et al.
Oncogene|October 18, 2011
Cross-talk between endothelial cells and tumor via delta-like ligand 4/Notch/PTEN signaling inhibits lung cancer growthX-Y Ding, J Ding, K Wu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 2, 2016
[Analysis of prognostic factors in Chinese patients with post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis]M Chen, Z F Xu, J Q Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 22, 2017
[The clinical characteristics, gene mutations and prognosis of chronic neutrophilic leukemia]Y J Cui, Q Jiang, J Q Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 4, 2024
[Clinical characteristics and prognosis of patients with myelodysplastic syndrome with a bone marrow nucleated erythroid cell proportion of greater than or equal to 50]Y P Zeng, B Li, T J Qin, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 17, 2025
[Myelodysplastic neoplasms with acute myeloid leukemia-like mutations: clinical features, molecular profiles, and prognosis]Z F Bao, L L Liu, B Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 15, 2021
[Genetic characteristics and prognostic values of RAS mutations in patients with myelofibrosis]J Y Wu, B Li, Y J Jia, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 1, 2019
[Clinical implications and prognostic value of TP53 gene mutation and deletion in patients with myelodysplastic syndromes]H J Huang, Z X Shi, B Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 3, 2016
[Frequency and clinical features of ASXL2 gene mutation in acute myeloid leukemia patients with AML1- ETO fusion gene positive]J X Zhao, X H Chen, J L Li, et al.
Pageof 11